Group One Trading’s Inozyme Pharma INZY Stock Holding History

Group One Trading’s Portfolio INZY Stock Details INZY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-3,715	Closed	-$9.2K	–	8268
2025 Q1	$3.38K	Buy	3,715 +3,500	+1,628%	+$4.85K	﹤0.01%	6806
2024 Q4	$596	Sell	215 -85	-28%	-$323	﹤0.01%	6981
2024 Q3	$1.57K	Hold	300	–	–	﹤0.01%	6205
2024 Q2	$1.34K	Sell	300 -881	-75%	-$4.27K	﹤0.01%	6308
2024 Q1	$9.05K	Buy	+1,181	New	+$6.48K	﹤0.01%	5922
2023 Q4	–	Sell	-1,009	Closed	-$3.58K	–	7766
2023 Q3	$4.24K	Sell	1,009 -1,100	-52%	-$5.6K	﹤0.01%	6780
2023 Q2	$11.7K	Buy	2,109 +1,483	+237%	+$8.77K	﹤0.01%	6305
2023 Q1	$3.59K	Buy	+626	New	+$1.65K	﹤0.01%	6427

Group One Trading's INZY Position: Q2 2025 in Review

Group One Trading sold out of Inozyme Pharma (INZY) in Q2 2025, closing a stake of 3,715 shares — an estimated $9.2K sold.

Group One Trading first reported a position in INZY in Q1 2023 and held it in 8 quarters. The position peaked at $11.7K in Q2 2023. 86 funds tracked by Wall St. Rank hold INZY as of Q2 2025.

Group One Trading reported no remaining Inozyme Pharma position as of Q2 2025 after selling out during the quarter.
Group One Trading sold 3,715 Inozyme Pharma shares in Q2 2025, an estimated $9.2K.
Group One Trading first reported a position in Inozyme Pharma in Q1 2023 and held it in 8 quarters.
Group One Trading's Inozyme Pharma position peaked at $11.7K in Q2 2023.
86 funds tracked by Wall St. Rank held Inozyme Pharma as of Q2 2025.

Based on Group One Trading's 13F filing for Q2 2025, filed 14 Aug 2025.